PermRock Royalty Trust
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PRT research report →
Price Chart
About the company
PermRock Royalty Trust's primary asset is an 80% net profits interest derived from oil and natural gas production properties located within the Permian Basin of Texas. These energy-producing assets were originally acquired by Boaz Energy II, LLC. The total subsurface area encompassed by these holdings amounts to 22,997 net acres.
- IPO
- 2018
- HQ
- Dallas, TX, US
Get TickerSpark's AI analysis on PRT
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $27.01M
- P/E
- 7.40
- Fwd P/E
- 1.59
- PEG
- -0.22
- P/S
- 5.95
- P/B
- 0.99
- EV/EBITDA
- 7.11
- Div Yield
- 10.14%
- Gross Margin
- 100.00%
- Op Margin
- 80.39%
- Net Margin
- 80.39%
- ROE
- 7.44%
- ROIC
- 13.39%
Latest fiscal year · YoY change
- Revenue
- $5.61M-6.8%
- Gross Profit
- $5.61M-6.8%
- Op Income
- $4.71M
- Net Income
- $4.71M-8.7%
- EPS
- $0.39-7.1%
- OCF Growth
- +0.0%
- FCF Growth
- +0.0%
- 52W High
- $4.12
- 52W Low
- $1.82
- 50D MA
- $2.21
- 200D MA
- $3.01
- Beta
- 0.41
- RSI (14)
- 50
- Avg Volume
- 54.15K
No earnings-call transcripts are available for PRT yet.
- Free Float
- 59.8%
- Shares Outstanding
- 12.17M
- Float Shares
- 7.27M
of shares held by institutions
21 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Susquehanna International Group, Llp | 31.10K | ▼ 9.52K |
| Cetera Investment Advisers | 15.35K | ▲ 15.35K |
| Jane Street Group, LLC | 10.20K | ▼ 8.82K |
| Royal Bank Of Canada | 5.00K | 0 |
| Ameriflex Group, Inc. | 5.00K | 0 |
| Barclays PLC | 3.22K | 0 |
| Tucker Asset Management LLC | 1.96K | ▲ 1.96K |
| Ubs Group AG | 1.75K | ▼ 585 |
| Morgan Stanley | 1.47K | 0 |
| Advisor Group Holdings, Inc. | 58 | ▼ 2.40K |
| Wells Fargo & Company/Mn | 1 | 0 |
Held by 4 ETFs
Biggest fund positions in PRT by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 31, 25 | Ustx, LLC | other | 0 |
| Mar 31, 25 | Boaz Energy II, LLC | sell | 4,884,861 |
| Jan 29, 24 | Boaz Energy II, LLC | sell | 3,200 |
| Jan 19, 24 | Boaz Energy II, LLC | sell | 400 |
| Jan 12, 24 | Boaz Energy II, LLC | sell | 200 |
| Dec 28, 23 | Boaz Energy II, LLC | sell | 200 |
| Dec 26, 23 | Boaz Energy II, LLC | sell | 1,700 |
| Dec 27, 23 | Boaz Energy II, LLC | sell | 2,600 |
| Dec 22, 23 | Boaz Energy II, LLC | sell | 2,200 |
| Dec 19, 23 | Boaz Energy II, LLC | sell | 5,500 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our PRT coverage
Recent articles, reports, and earnings notes.
No research on PRT yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PRT report →PermRock Royalty Trust Declares Monthly Cash Distribution
prnewswire.com · Jul 21
PermRock Royalty Trust Declares Monthly Cash Distribution
prnewswire.com · Jun 18
PermRock Royalty Trust Declares Monthly Cash Distribution
prnewswire.com · May 18
The structural problem no oil price recovery can fix for PRT investors
247wallst.com · May 4
PermRock Royalty Trust Declares Monthly Cash Distribution
prnewswire.com · Apr 20
Prelude Therapeutics Presents Preclinical Data from Development Candidate, PRT13722, a First-in-Class, Orally Bioavailable, Potent and Highly Selective KAT6A Degrader at American Association for Cancer Research (AACR) Annual Meeting 2026
globenewswire.com · Apr 20
PermRock Royalty Trust Declares Monthly Cash Distribution
prnewswire.com · Mar 20
Prelude Therapeutics Announces Acceptance of Preclinical Abstract for PRT13722, a First-in-Class Oral KAT6A Selective Degrader at the 2026 AACR Annual Meeting
globenewswire.com · Mar 17
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.